The causal relationship between tea consumption and total-body (TB) bone mineral density (BMD).
ArriVent partners with Alphamab to develop ADCs for cancer
The partnership will utilise the technologies of Alphamab to detect promising ADC candidates for oncology indications. Credit: Nemes Laszlo/Shutterstock. ArriVent BioPharma has entered a partnership